
DiaMedica to collaborate with the Sanford Project
DiaMedica Inc., (TSX-V: DMA) is pleased to announce the commencement of a research collaboration with The Sanford Project, a world leader in type 1 diabetes (T1D) research. The Sanford Project is one of the initiatives established after Denny Sanford’s historic $400 M gift to Sanford Health in 2007. The Project aims to cure T1D through […]